Orient Bio has high-quality specific pathogen-free (SPF) research rabbits, and is moving to expand their supply.


Orient Bio Expands Supply of High-Quality SPF Research Rabbits View original image

According to Orient Bio on October 12, the company is applying to its Jeongeup Center the production and quality management systems it secured through a technical partnership with Japan's Kitayama Rabes, with the aim of reducing its reliance on imported research rabbits. It is stepping up domestic production and supply in earnest. The strategy is to reduce supply uncertainty caused by changes in overseas supply chains, ease the burdens of quarantine and transportation, and provide biological materials tailored to research schedules and requirements.


The company plans to continue strengthening the production and quality management systems at its Jeongeup Center and expand its supply of biological materials to meet growing demand from domestic and international biotechnology companies and research institutions. It also intends to enhance its supply competitiveness by improving facility utilization and operational efficiency as production expands.


Orient Bio produces high-quality SPF research rabbits through systematic breeding facilities and biological monitoring. These laboratory animals are managed to ensure they are free of designated specific pathogens. They are used in a range of nonclinical studies, including eye and skin irritation tests, as well as research on vaccines, biopharmaceuticals, medical devices, and toxicity assessment.



An Orient Bio representative said, "Researchers can focus on their work and achieve results only if they can reliably obtain high-quality laboratory animals when needed. Building on our global technical partnerships and production infrastructure, we will continue to develop into an advanced biological materials infrastructure company that eases the burden on researchers and contributes to the growth of Korea's biotechnology industry."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing